• Medientyp: E-Artikel
  • Titel: Development of Beta-Amyloid-Specific CAR-Tregs for the Treatment of Alzheimer’s Disease
  • Beteiligte: Saetzler, Valerie; Riet, Tobias; Schienke, Andrea; Henschel, Pierre; Freitag, Kiara; Haake, Alexander; Heppner, Frank L.; Buitrago-Molina, Laura Elisa; Noyan, Fatih; Jaeckel, Elmar; Hardtke-Wolenski, Matthias
  • Erschienen: MDPI AG, 2023
  • Erschienen in: Cells, 12 (2023) 16, Seite 2115
  • Sprache: Englisch
  • DOI: 10.3390/cells12162115
  • ISSN: 2073-4409
  • Schlagwörter: General Medicine
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:p>Background: Alzheimer’s disease (AD) is a neurodegenerative disease that remains uncured. Its pathogenesis is characterized by the formation of β-amyloid (Aβ) plaques. The use of antigen-specific regulatory T cells (Tregs) through adoptive transfer has shown promise for the treatment of many inflammatory diseases, although the effectiveness of polyspecific Tregs is limited. Obtaining a sufficient number of antigen-specific Tregs from patients remains challenging. Aims and Methods: To address this problem, we used an antibody-like single-chain variable fragment from a phage library and subsequently generated a chimeric antigen receptor (CAR) targeting β-amyloid. Results: The β-amyloid-specific CARs obtained were stimulated by both recombinant and membrane-bound Aβ isolated from the murine brain. The generated CAR-Tregs showed a normal Treg phenotype, were antigen-specific activatable, and had suppressive capacity. Conclusion: This study highlights the potential of CAR technology to generate antigen-specific Tregs and presents novel approaches for developing functional CARs.</jats:p>
  • Zugangsstatus: Freier Zugang